Prognostic benefit from an early invasive strategy in patients with non-ST elevation acute coronary syndrome (NSTEACS): evaluation of the new risk stratification in the NSTEACS European guidelines

Author(s):  
Jesús Martinón-Martínez ◽  
Belén Álvarez Álvarez ◽  
Teba González Ferrero ◽  
Federico García-Rodeja Arias ◽  
Óscar Otero García ◽  
...  
Heart ◽  
2010 ◽  
Vol 96 (Suppl 3) ◽  
pp. A139-A139
Author(s):  
L. Bei ◽  
L. Zhiliang ◽  
Y. Quanneng ◽  
J. Wen ◽  
T. Danping

2020 ◽  
Vol 28 (S1) ◽  
pp. 88-92
Author(s):  
G. W. A. Aarts ◽  
J. Q. Mol ◽  
C. Camaro ◽  
J. Lemkes ◽  
N. van Royen ◽  
...  

2020 ◽  
Vol 16 (4) ◽  
pp. 217-226
Author(s):  
Dominique N van Dongen ◽  
Rudolf T Tolsma ◽  
Marion J Fokkert ◽  
Erik A Badings ◽  
Aize van der Sluis ◽  
...  

Background: It is not yet investigated whether referral decisions based on prehospital risk stratification of non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) by the complete History, ECG, Age, Risk factors and initial Troponin (HEART) score are feasible and safe. Hypothesis: Implementation of referral decisions based on the prehospital acquired HEART score in patients with suspected NSTE-ACS is feasible and not inferior to routine management in the occurrence of major adverse cardiac events within 45 days. Study design & methods: FamouS Triage 3 is a feasibility study with a before–after sequential design. The aim is to assess whether prehospital HEART-score management including point-of-care troponin measurement is feasible and noninferior to routine management. Primary end point is the occurrence of major adverse cardiac events within 45 days. Conclusion: If referral decisions based on prehospital acquired risk stratification are feasible and noninferior this can become the new prehospital management in suspected NSTE-ACS.


Sign in / Sign up

Export Citation Format

Share Document